Delivery Order SPE2DR25D2012-SPE2DR26F1BRD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Glimepiride 2 mg tablets in quantities of 100 units, with a ceiling value of $1,260.82 and an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,207.23 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 2, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $2,237.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a small-value pharmaceutical procurement executed under a competitive, non-set-aside process. The delivery will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,799.68 to AmerisourceBergen Drug Corp for Glimepiride 1 mg tablets in quantities of 100 units. The contract is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Glimepiride is an oral medication used in the...
- The Defense Logistics Agency awarded a $2,459.72 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg on December 3, 2025, with completion required by December 4, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor at its Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the company's extensive federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.96 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,210.66 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 MG tablets (100-count units) under a firm fixed-price contract. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025, and does not utilize a set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under...
- The Defense Logistics Agency awarded a delivery order valued at $7,878.18 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This non-set-aside, competitively awarded contract reflects firm fixed pricing and was issued on August 19, 2025, with an ultimate completion date of August 20, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 7, 2026, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $3,130.05 and an ultimate completion date of January 8, 2026. The contract carries no set-aside designation. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,319,446 units of 2 mg glimepiride tablets. The $1,728.22 award has a completion date of January 16, 2024 and was made on January 12, 2024. This delivery order is part of a larger indefinite delivery contract held by AmerisourceBergen Drug Corp to provide pharmaceuticals and medical supplies to DLA Troop Support...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BRDDelivery Order
The Defense Logistics Agency awarded a $2,583.75 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Glimepiride 2 mg tablets in quantities of 100. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by January 7, 2026. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a discrete task under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, particularly the Department of Defense and military treatment facilities. The company's parent entity, Cencora, Inc., holds a substantial IDC valued at up to $999,999,999.00 with the DLA Troop Support Medical through December 2031, which serves as the comprehensive vehicle for delivering pharmaceuticals, vaccines, medical devices, and related healthcare commodities to support military health programs globally. The Glimepiride delivery order fulfills a component of diabetes medication supply needs within the broader federal pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/5/26 |